5Chalfie MY, Tu G, Euskirchen WW, et al. Green fluorescent protein as a marker for gene expression. Science, 1994, 263(5148): 802-805.
6James DB, Ching-Tsan H. Recombinant plasmid retention and expression in bacterial biofilm cultures. Water Science and Technology, 1995, 31(2): 105-115.
7Barnard FM, Maxell A. Interaction between DNA gyrase and quinolones: effects of alanine mutation at gyrA subunit residues Ser83 and Asp87. Antimicrob Agents Chemother, 2001, 45(7): 1994-2000.
8Xian-Zhi L, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs, 2004, 64 (1): 1-31.
9Rodney MD. Biofilm: microbial life on surfaces. Emerg Infect Dis, 2002, 8(9): 881-890.
10Sauer K, Camper AK, Ehrlich GD, et al. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol, 2002, 184(4): 1140-1154.
1Norez C,Noel S,Wilke M,et al.Rescue of functionaldelF508-CFTR channels in cystic fibrosis epithelial cells bythe a-glucosidase inhibitor miglustat[J].FEBS Lett,2006,580(8):2081.
2Peter J,Mogayzel,J,Patrick A F.Update in Cystic Fibrosis2009[J].Am J Respir Crit Care Med,2010,181(6):539.
3Carter C J.Pathogen and autoantigen homologous regionswithin the cystic fibrosis transmembrane conductance regula-tor(CFTR)protein suggest an autoimmune treatable compo-nent of cystic fibrosis[J].FEMS Immunol Med Microbiol,2011,62(2):197.
4Oermann C M,McCoy K A,Retsch-Bogart G Z,et al.Ef-fect of multiple Aztreonam Lysine for Inhalation(AZLI)cy-cles on disease-related endpoints and safety in patients withcystic fibrosis(CF)and Pseudomonas aeruginosa(PA):in-terim analysis of 12 month data[J].J Cystic Fib,2008,7(suppl):S25.
5Retsch-Bogart G Z,Burns J L,Otto K L,et al.A phase 2study of aztreonam lysine for inhalation to treat patients withcystic fibrosis and Pseudomonas aeruginosa infection[J].Pe-diatr Pulmonol,2008,43(1):47.
6Quittner A L,McCoy K,Montgomery B.Inhaled antibioticsto treat stable patients with cystic fibrosis and Pseudomonasaeruginosa(PA):measuring patient perception of symptomimprovement[J].Pediatr Pulmonol,2007,42(4):301.
7Pamp S J,Gjermansen M,Johansen H K,et al.Toleranceto the antimicrobial peptide colistin in Pseudomonas aerugi-nosa biofilms is linked to metabolically active cells,and de-pends on the pmr and mexAB-oprM genes[J].Mol Micro-biol,2008,68(1):223.
8Hoffmann N,Rasmussen T B,Jensen P,et al.Novelmouse model of chronic Pseudomonas aeruginosa lung infec-tion mimicking cystic fibrosis[J].Infect Immun,2005,73(4):2504.
9Kolpen M,Hansen C R,Bjarnsholt T,et al.Polymorphonu-clear leucocytes consume oxygen in sputum from chronicPseudomonas aeruginosa pneumonia in cystic fibrosis[J].Thorax,2010,65(1):57.
10Duff A J,Latchford G J.Inhaled medication and inhalationdevices for lung disease in patients with cystic fibrosis:pooradherence and the need to address it[J].J Cyst Fibros,2010,9(6):455.
